Description
Zolacid (Zoledronic Acid) Concentrate for Infusions 4 mg/5 ml Vial 5 ml №1
Ingredients:
Each vial contains 4 mg of zoledronic acid in 5 ml of concentrate.
Dosage:
The recommended dosage of Zolacid for adults is 4 mg infused over at least 15 minutes every 6 months.
Indications:
- Zolacid is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
- It is also used for the treatment of osteoporosis in men.
- Additionally, Zolacid is prescribed for the treatment of Paget’s disease of bone.
Contraindications:
Do not use Zolacid if you have low levels of calcium in your blood or if you are allergic to zoledronic acid.
Directions:
Zolacid should be administered by a healthcare professional as an intravenous infusion. It is important to follow the recommended dosage and infusion rate to minimize the risk of adverse reactions.
Scientific Evidence:
Zoledronic acid, the active ingredient in Zolacid, is a bisphosphonate that inhibits bone resorption. Studies have shown its efficacy in increasing bone mineral density and reducing fracture risk in osteoporosis patients. Research in the Journal of Bone and Mineral Research demonstrated a 70% reduction in vertebral fractures over 3 years.
Additional Information:
Zolacid has shown significant improvements in bone health and has a good safety profile based on clinical trials. Monitoring calcium levels and ensuring adequate vitamin D intake are important during treatment to support bone health.
